Anjarium To Pioneer Next-Generation Non-Viral Gene Therapies

Founder Says $61m Financing Will Allow ‘Developmental Lift Off’

 
• By Sten Stovall
  
Emerging Company Profile: Anjarium Biosciences
Anjarium Mission ‘To Correct Viral Gene Therapy Shortcomings’ • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business